ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Circadian Rhythm Attenuates O.S.A. Vascular Function 11/07/25"
Episode Synopsis
Welcome to Cardiology Today – Recorded November 07, 2025. This episode summarizes 5 key cardiology studies on topics like vascular endothelial function and adolescence. Key takeaway: Circadian Rhythm Attenuates O.S.A. Vascular Function.
Article Links:
Article 1: Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial. (Circulation)
Article 2: Role of GLP-1 Receptor Agonists in Managing Cancer Therapy-Related Cardiac Dysfunction. (Journal of the American Heart Association)
Article 3: Burden of Atherosclerosis and Outcomes of Acute Pulmonary Embolism: A Post Hoc Analysis of the Hokusai-VTE Trial. (Journal of the American Heart Association)
Article 4: Adhering to Life’s Essential 8 Is Associated With Greater Bone Mineral Accrual During Childhood and Adolescence. (Journal of the American Heart Association)
Article 5: Endogenous Circadian System Attenuates Nighttime Vascular Endothelial Function in People With Untreated Obstructive Sleep Apnea. (Journal of the American Heart Association)
Full episode page: https://podcast.explainheart.com/podcast/circadian-rhythm-attenuates-o-s-a-vascular-function-11-07-25/
Featured Articles
Article 1: Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial.
Journal: Circulation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41200807
Summary: The ES-BempeDACS Randomized Clinical Trial was designed to investigate the efficacy and safety of triple versus dual lipid-lowering therapy in patients with acute coronary syndrome. This study aimed to determine if combining bempedoic acid with high-intensity statins and ezetimibe could more effectively achieve low-density lipoprotein cholesterol goals. Current guidelines suggest a stepwise approach, but this trial explored an earlier intensive strategy from the onset of acute coronary syndrome. Its findings are anticipated to clarify optimal lipid-lowering strategies in this high-risk population.
Article 2: Role of GLP-1 Receptor Agonists in Managing Cancer Therapy-Related Cardiac Dysfunction.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41195790
Summary: This retrospective cohort study utilized the TriNetX research network to explore the role of glucagon-like peptide-1 receptor agonists in managing cancer therapy-related cardiac dysfunction. The research focused on adults aged 18 years and older who had a history of cancer, received antineoplastic therapy, and subsequently developed this cardiac complication. While glucagon-like peptide-1 receptor agonists are known for their cardioprotective properties, their specific application in cancer therapy-related cardiac dysfunction had not been previously investigated. This study established a framework to analyze real-world data on this potential therapeutic strategy.
Article 3: Burden of Atherosclerosis and Outcomes of Acute Pulmonary Embolism: A Post Hoc Analysis of the Hokusai-VTE Trial.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41195787
Summary: Trial. This post hoc analysis of the Hokusai-V.T.E. trial investigated the association between the burden of atherosclerosis and long-term clinical outcomes in patients experiencing acute pulmonary embolism. The study specifically assessed the presence and extent of atherosclerotic disease across multiple vascular territories, including coronary, cerebral, and peripheral, or in a single territory, or its absence. This research aimed to determine if the extent of atherosclerotic disease has prognostic implications for individuals affected by venous thromboembolism. Identifying these associations could improve risk stratification and guide management strategies for patients with acute pulmonary embolism.
Article 4: Adhering to Life’s Essential 8 Is Associated With Greater Bone Mineral Accrual During Childhood and Adolescence.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41195786
Summary: This nationwide cross-sectional survey investigated the relationship between cardiovascular health and bone mineral accrual in 11468 Chinese children and adolescents aged 6 to 18 years. Cardiovascular health was assessed using the American Heart Association’s Life’s Essential 8 metrics, encompassing four behavioral metrics including diet and physical activity, and four factor metrics such as body mass index and blood pressure. The study found that adhering to Life’s Essential 8 was associated with greater bone mineral accrual during childhood and adolescence. This discovery highlights the critical importance of early cardiovascular health promotion for concurrently optimizing bone development and potentially reducing future osteoporosis risk.
Article 5: Endogenous Circadian System Attenuates Nighttime Vascular Endothelial Function in People With Untreated Obstructive Sleep Apnea.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41195783
Summary: This study investigated the role of the endogenous circadian system in attenuating nighttime vascular endothelial function in individuals with untreated obstructive sleep apnea. It hypothesized that the increased incidence of adverse cardiovascular events, such as myocardial infarction, observed at night in obstructive sleep apnea patients is linked to the circadian system’s influence on vascular function. The research demonstrated that the endogenous circadian system indeed attenuates nighttime vascular endothelial function in this population. This finding provides a crucial mechanistic understanding of the heightened cardiovascular risk in obstructive sleep apnea, potentially paving the way for chronotherapeutic approaches.
Transcript
Today’s date is November 07, 2025. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial. The ES-BempeDACS Randomized Clinical Trial was designed to investigate the efficacy and safety of triple versus dual lipid-lowering therapy in patients with acute coronary syndrome. This study aimed to determine if combining bempedoic acid with high-intensity statins and ezetimibe could more effectively achieve low-density lipoprotein cholesterol goals. Current guidelines suggest a stepwise approach, but this trial explored an earlier intensive strategy from the onset of acute coronary syndrome. Its findings are anticipated to clarify optimal lipid-lowering strategies in this high-risk population.
Article number two. Role of G.L.P.-1 Receptor Agonists in Managing Cancer Therapy-Related Cardiac Dysfunction. This retrospective cohort study utilized the TriNetX research network to explore the role of glucagon-like peptide-1 receptor agonists in managing cancer therapy-related cardiac dysfunction. The research focused on adults aged 18 years and older who had a history of cancer, received antineoplastic therapy, and subsequently developed this cardiac complication. While glucagon-like peptide-1 receptor agonists are known for their cardioprotective properties, their specific application in cancer therapy-related cardiac dysfunction had not been previously investigated. This study established a framework to analyze real-world data on this potential therapeutic strategy.
Article number three. Burden of Atherosclerosis and Outcomes of Acute Pulmonary Embolism: A Post Hoc Analysis of the Hokusai-V.T.E. Trial. This post hoc analysis of the Hokusai-V.T.E. trial investigated the association between the burden of atherosclerosis and long-term clinical outcomes in patients experiencing acute pulmonary embolism. The study specifically assessed the presence and extent of atherosclerotic disease across multiple vascular territories, including coronary, cerebral, and peripheral, or in a single territory, or its absence. This research aimed to determine if the extent of atherosclerotic disease has prognostic implications for individuals affected by venous thromboembolism. Identifying these associations could improve risk stratification and guide management strategies for patients with acute pulmonary embolism.
Article number four. Adhering to Life’s Essential 8 Is Associated With Greater Bone Mineral Accrual During Childhood and Adolescence. This nationwide cross-sectional survey investigated the relationship between cardiovascular health and bone mineral accrual in 11468 Chinese children and adolescents aged 6 to 18 years. Cardiovascular health was assessed using the American Heart Association’s Life’s Essential 8 metrics, encompassing four behavioral metrics including diet and physical activity, and four factor metrics such as body mass index and blood pressure. The study found that adhering to Life’s Essential 8 was associated with greater bone mineral accrual during childhood and adolescence. This discovery highlights the critical importance of early cardiovascular health promotion for concurrently optimizing bone development and potentially reducing future osteoporosis risk.
Article number five. Endogenous Circadian System Attenuates Nighttime Vascular Endothelial Function in People With Untreated Obstructive Sleep Apnea. This study investigated the role of the endogenous circadian system in attenuating nighttime vascular endothelial function in individuals with untreated obstructive sleep apnea. It hypothesized that the increased incidence of adverse cardiovascular events, such as myocardial infarction, observed at night in obstructive sleep apnea patients is linked to the circadian system’s influence on vascular function. The research demonstrated that the endogenous circadian system indeed attenuates nighttime vascular endothelial function in this population. This finding provides a crucial mechanistic understanding of the heightened cardiovascular risk in obstructive sleep apnea, potentially paving the way for chronotherapeutic approaches.
Thank you for listening. Don’t forget to subscribe.
Keywords
vascular endothelial function, adolescence, statins, cardiovascular health, osteoporosis prevention, low-density lipoprotein cholesterol, retrospective cohort study, obstructive sleep apnea, myocardial infarction, polyvascular disease, antineoplastic therapy, glucagon-like peptide-1 receptor agonists, bone mineral accrual, childhood, acute coronary syndrome, bempedoic acid, venous thromboembolism, prognosis, ezetimibe, cancer therapy-related cardiac dysfunction, Life’s Essential 8, pulmonary embolism, circadian system, cardiovascular risk, atherosclerosis.
About
Concise summaries of cardiovascular research for professionals.
Subscribe • Share • FollowThe post Circadian Rhythm Attenuates O.S.A. Vascular Function 11/07/25 first appeared on Cardiology Today.
Article Links:
Article 1: Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial. (Circulation)
Article 2: Role of GLP-1 Receptor Agonists in Managing Cancer Therapy-Related Cardiac Dysfunction. (Journal of the American Heart Association)
Article 3: Burden of Atherosclerosis and Outcomes of Acute Pulmonary Embolism: A Post Hoc Analysis of the Hokusai-VTE Trial. (Journal of the American Heart Association)
Article 4: Adhering to Life’s Essential 8 Is Associated With Greater Bone Mineral Accrual During Childhood and Adolescence. (Journal of the American Heart Association)
Article 5: Endogenous Circadian System Attenuates Nighttime Vascular Endothelial Function in People With Untreated Obstructive Sleep Apnea. (Journal of the American Heart Association)
Full episode page: https://podcast.explainheart.com/podcast/circadian-rhythm-attenuates-o-s-a-vascular-function-11-07-25/
Featured Articles
Article 1: Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial.
Journal: Circulation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41200807
Summary: The ES-BempeDACS Randomized Clinical Trial was designed to investigate the efficacy and safety of triple versus dual lipid-lowering therapy in patients with acute coronary syndrome. This study aimed to determine if combining bempedoic acid with high-intensity statins and ezetimibe could more effectively achieve low-density lipoprotein cholesterol goals. Current guidelines suggest a stepwise approach, but this trial explored an earlier intensive strategy from the onset of acute coronary syndrome. Its findings are anticipated to clarify optimal lipid-lowering strategies in this high-risk population.
Article 2: Role of GLP-1 Receptor Agonists in Managing Cancer Therapy-Related Cardiac Dysfunction.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41195790
Summary: This retrospective cohort study utilized the TriNetX research network to explore the role of glucagon-like peptide-1 receptor agonists in managing cancer therapy-related cardiac dysfunction. The research focused on adults aged 18 years and older who had a history of cancer, received antineoplastic therapy, and subsequently developed this cardiac complication. While glucagon-like peptide-1 receptor agonists are known for their cardioprotective properties, their specific application in cancer therapy-related cardiac dysfunction had not been previously investigated. This study established a framework to analyze real-world data on this potential therapeutic strategy.
Article 3: Burden of Atherosclerosis and Outcomes of Acute Pulmonary Embolism: A Post Hoc Analysis of the Hokusai-VTE Trial.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41195787
Summary: Trial. This post hoc analysis of the Hokusai-V.T.E. trial investigated the association between the burden of atherosclerosis and long-term clinical outcomes in patients experiencing acute pulmonary embolism. The study specifically assessed the presence and extent of atherosclerotic disease across multiple vascular territories, including coronary, cerebral, and peripheral, or in a single territory, or its absence. This research aimed to determine if the extent of atherosclerotic disease has prognostic implications for individuals affected by venous thromboembolism. Identifying these associations could improve risk stratification and guide management strategies for patients with acute pulmonary embolism.
Article 4: Adhering to Life’s Essential 8 Is Associated With Greater Bone Mineral Accrual During Childhood and Adolescence.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41195786
Summary: This nationwide cross-sectional survey investigated the relationship between cardiovascular health and bone mineral accrual in 11468 Chinese children and adolescents aged 6 to 18 years. Cardiovascular health was assessed using the American Heart Association’s Life’s Essential 8 metrics, encompassing four behavioral metrics including diet and physical activity, and four factor metrics such as body mass index and blood pressure. The study found that adhering to Life’s Essential 8 was associated with greater bone mineral accrual during childhood and adolescence. This discovery highlights the critical importance of early cardiovascular health promotion for concurrently optimizing bone development and potentially reducing future osteoporosis risk.
Article 5: Endogenous Circadian System Attenuates Nighttime Vascular Endothelial Function in People With Untreated Obstructive Sleep Apnea.
Journal: Journal of the American Heart Association
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41195783
Summary: This study investigated the role of the endogenous circadian system in attenuating nighttime vascular endothelial function in individuals with untreated obstructive sleep apnea. It hypothesized that the increased incidence of adverse cardiovascular events, such as myocardial infarction, observed at night in obstructive sleep apnea patients is linked to the circadian system’s influence on vascular function. The research demonstrated that the endogenous circadian system indeed attenuates nighttime vascular endothelial function in this population. This finding provides a crucial mechanistic understanding of the heightened cardiovascular risk in obstructive sleep apnea, potentially paving the way for chronotherapeutic approaches.
Transcript
Today’s date is November 07, 2025. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial. The ES-BempeDACS Randomized Clinical Trial was designed to investigate the efficacy and safety of triple versus dual lipid-lowering therapy in patients with acute coronary syndrome. This study aimed to determine if combining bempedoic acid with high-intensity statins and ezetimibe could more effectively achieve low-density lipoprotein cholesterol goals. Current guidelines suggest a stepwise approach, but this trial explored an earlier intensive strategy from the onset of acute coronary syndrome. Its findings are anticipated to clarify optimal lipid-lowering strategies in this high-risk population.
Article number two. Role of G.L.P.-1 Receptor Agonists in Managing Cancer Therapy-Related Cardiac Dysfunction. This retrospective cohort study utilized the TriNetX research network to explore the role of glucagon-like peptide-1 receptor agonists in managing cancer therapy-related cardiac dysfunction. The research focused on adults aged 18 years and older who had a history of cancer, received antineoplastic therapy, and subsequently developed this cardiac complication. While glucagon-like peptide-1 receptor agonists are known for their cardioprotective properties, their specific application in cancer therapy-related cardiac dysfunction had not been previously investigated. This study established a framework to analyze real-world data on this potential therapeutic strategy.
Article number three. Burden of Atherosclerosis and Outcomes of Acute Pulmonary Embolism: A Post Hoc Analysis of the Hokusai-V.T.E. Trial. This post hoc analysis of the Hokusai-V.T.E. trial investigated the association between the burden of atherosclerosis and long-term clinical outcomes in patients experiencing acute pulmonary embolism. The study specifically assessed the presence and extent of atherosclerotic disease across multiple vascular territories, including coronary, cerebral, and peripheral, or in a single territory, or its absence. This research aimed to determine if the extent of atherosclerotic disease has prognostic implications for individuals affected by venous thromboembolism. Identifying these associations could improve risk stratification and guide management strategies for patients with acute pulmonary embolism.
Article number four. Adhering to Life’s Essential 8 Is Associated With Greater Bone Mineral Accrual During Childhood and Adolescence. This nationwide cross-sectional survey investigated the relationship between cardiovascular health and bone mineral accrual in 11468 Chinese children and adolescents aged 6 to 18 years. Cardiovascular health was assessed using the American Heart Association’s Life’s Essential 8 metrics, encompassing four behavioral metrics including diet and physical activity, and four factor metrics such as body mass index and blood pressure. The study found that adhering to Life’s Essential 8 was associated with greater bone mineral accrual during childhood and adolescence. This discovery highlights the critical importance of early cardiovascular health promotion for concurrently optimizing bone development and potentially reducing future osteoporosis risk.
Article number five. Endogenous Circadian System Attenuates Nighttime Vascular Endothelial Function in People With Untreated Obstructive Sleep Apnea. This study investigated the role of the endogenous circadian system in attenuating nighttime vascular endothelial function in individuals with untreated obstructive sleep apnea. It hypothesized that the increased incidence of adverse cardiovascular events, such as myocardial infarction, observed at night in obstructive sleep apnea patients is linked to the circadian system’s influence on vascular function. The research demonstrated that the endogenous circadian system indeed attenuates nighttime vascular endothelial function in this population. This finding provides a crucial mechanistic understanding of the heightened cardiovascular risk in obstructive sleep apnea, potentially paving the way for chronotherapeutic approaches.
Thank you for listening. Don’t forget to subscribe.
Keywords
vascular endothelial function, adolescence, statins, cardiovascular health, osteoporosis prevention, low-density lipoprotein cholesterol, retrospective cohort study, obstructive sleep apnea, myocardial infarction, polyvascular disease, antineoplastic therapy, glucagon-like peptide-1 receptor agonists, bone mineral accrual, childhood, acute coronary syndrome, bempedoic acid, venous thromboembolism, prognosis, ezetimibe, cancer therapy-related cardiac dysfunction, Life’s Essential 8, pulmonary embolism, circadian system, cardiovascular risk, atherosclerosis.
About
Concise summaries of cardiovascular research for professionals.
Subscribe • Share • FollowThe post Circadian Rhythm Attenuates O.S.A. Vascular Function 11/07/25 first appeared on Cardiology Today.
In God we trust